- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04884698
"Electromagnetical Stimulation of Phrenic Nerve to Generate Contraction of the Diaphragm"
"Electromagnetical Stimulation of the Phrenic Nerve to Generate Contraction of the Diaphragm in Healthy Subjects and Anaesthetized and Intubated Patients - a Feasibility Study"
The scientific study is intended to show that external non-invasive electromagnetic stimulation can be used to safely and effectively stimulate the phrenic nerve in awake healthy subjects as well as in ventilated, anesthetized patients and that the stimulation can generate a diaphragmatic contraction that generates significant breath volume - a Controlled Own Breath (COB).
Also of interest is the reproducibility of the generated diaphragmatic movements and the reliability of different feedback signals for detecting the generated diaphragmatic contraction. This applies to inspiration and expiration detection for subsequent synchronization mechanisms of the magnetic stimulator for patient-initiated breathing as well as to contraction intensity. Further, the characterization of the position finding process is of great importance, so that technical developments can further simplify the process of coil positioning in the future. The possible occurrence of discomfort and pain sensation will also be investigated in awake healthy volunteers. Different stimulation protocols will be used.
Finally, it will be investigated whether an adjusted coil position still triggers reproducible diaphragmatic contractions after removal and repositioning in the same configuration. The knowledge gained will be used to further develop the technique and to prepare a study in critically ill, ventilated patients where the diaphragmatic muscle is to be treated preventively by stimulating the phrenic nerve, in order to prevent atrophy of the muscle.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nottwil, Switzerland
- Swiss Paraplegic Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Persons aged > 18 years
- Applicable for Group 2: planned for elective surgery
- No relevant pre-existing conditions - corresponding to American Society of Anesthesiologists (ASA) level of I-II.
- Written informed consent by the patient for participation in the study given
Exclusion Criteria:
- chronic lung diseases (bronchial asthma, COPD)
- known diaphragmatic weakness
- known neurological conditions with motor muscle weakness
- known paralysis of the phrenic nerve
- conditions that limit the mobility of the diaphragm (high intra-abdominal pressure, ascites, BMI >30)
- not able to read and understand the national language German
- skin lesions, infections or strictures in the neck area
- persons with Implanted cardiac support systems (pacemaker, implanted defibrillator)
- persons with implanted medical pumps
- pregnant women
- persons deprived of liberty by administrative or judicial decision or under legal guardianship.
- Participation in another clinical trial
Applicable for group 2 (intubated and mechanically ventilated) patients: Exclusion criteria at the time of stimulation:
- Unstable patient after induction of anesthesia and intubation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Phrenic nerve stimulation with Stimit Activator
|
The Stimit Activator Device is composed of three components.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in airway pressure / endpoint Group 1:
Time Frame: During stimulation
|
The primary outcome / endpoint is the change in airway pressure at the mouth during stimulation as seen with or without the use of the ventilator
|
During stimulation
|
Discomfort / pain during stimulation measured by Visual Analogue Scale / endpoint Group 1:
Time Frame: During stimulation
|
The primary outcome / endpoint is the level of discomfort / pain during stimulation, measured by Visual Analogue Scale(0-100, with 100 being worst pain / discomfort)
|
During stimulation
|
Change in airway pressure / endpoint Group 2:
Time Frame: During stimulation
|
The primary outcome / endpoint is the change in airway pressure during stimulation as seen with or without the use of the ventilator during stimulation.
|
During stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diaphragmatic contraction
Time Frame: During stimulation
|
Diaphragmatic contraction at 20 percent / 30 percent / 40 percent stimulation intensity at the optimal stimulation site, at 25 Hz and 2s stimulation time
|
During stimulation
|
Feedback signals
Time Frame: During stimulation
|
Change of the maximum value of the feedback signals in percent of the maximum depending on the coil position (in 0.5 cm steps; at least 3 steps in each direction)
|
During stimulation
|
Time stimulation start to end
Time Frame: During stimulation
|
Time (mean value & standard deviation) between stimulation start and stimulation end (trigger signal start and end) until the feedback signals from:
|
During stimulation
|
Correlation stimulation intensity and diaphragm contraction
Time Frame: During stimulation
|
Correlation between stimulation intensity (power output in percent) and diaphragm contraction, measured by tidal volume, at the optimal coil position at given frequency (25 Hz) and given stimulation duration
|
During stimulation
|
Optimal stimulation site - distance
Time Frame: During stimulation
|
Distance from anatomical landmark (a) to optimal stimulation site (b) and phrenic nerve (c) using ultrasound and between b and c
|
During stimulation
|
Optimal stimulation site - time
Time Frame: During stimulation
|
Time from the start of coil positioning to finding a coil positioning which produces the maximum diaphragmatic contraction at a given stimulation intensity and frequency of 25 Hz
|
During stimulation
|
Tidal volumes
Time Frame: During stimulation
|
The mean and standard deviation of generated tidal volumes for ten stimulations performed without the subject being ventilated
|
During stimulation
|
Skin reactions / musle activation
Time Frame: During stimulation
|
For Group 1: evaluation of stimulation-induced local skin reactions or muscle activation leading to paresthesia in the dental area
|
During stimulation
|
Safety outcome
Time Frame: During stimulation and postoperatively, usually within 2-3 hours
|
The safety outcome/ endpoint is the occurrence of the following events during stimulation:
|
During stimulation and postoperatively, usually within 2-3 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Baumberger, MD, Swiss Paraplegic Center Nottwil
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Stimit swiss I
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
PfizerRecruitingHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
NeuShen TherapeuticsRecruiting
-
GEN İlaç ve Sağlık Ürünleri A.Ş.Sulfateq B.V.Recruiting
-
Bio-innova Co., LtdNot yet recruiting
-
Bio-innova Co., LtdNot yet recruiting
Clinical Trials on Stimit Activator
-
Al-Azhar UniversityEnrolling by invitation
-
Spinal Missions, Inc., LLCCompleted
-
Université du Québec a MontréalCompleted
-
Medical University of GrazCompletedPain in Leg, Unspecified | Knee SprainAustria
-
Institut Franco Europeen de ChiropratiqueUnknown
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
RenJi HospitalCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Slovakia
-
Anglo-European College of ChiropracticUnknownLow Back PainUnited Kingdom